What this service is:

Life Sciences Law & Industry Report connects the dots among the many disciplines that make up the burgeoning life sciences industry, with biweekly updates on current regulatory, legislative, and legal issues.

What it helps you do:

• Become familiar with the global, billion-dollar life sciences industry -- defined as the use of advanced and emerging technologies to develop solutions that enhance human health and combat disease.
• Understand how rapid expansion of the industry has spurred both government and private efforts to encourage research, reward innovation, fund supporting infrastructure, and protect the public.
• Be thoroughly informed of federal, state, and major international legislation, regulations, policies, and standards concerning the life sciences industry -- everything from biotechnology to patents to counterterrorism.
• Find out about newly issued court and administrative decisions affecting the life sciences, as well as current government enforcement activity, pending litigation, and settlements.
• Get essential details on Congressional hearings, bills, and amendments that may have an impact on the industry.
• Consider the views of practicing attorneys, government regulators, and other experts in Analysis & Perspective articles.
• Consult just one convenient source for information on the myriad legal and business issues affecting the life sciences.
• Quickly locate news, cases, and more in this fully indexed, easily searchable service.
• Benefit from objective, unbiased news equally useful to lawyers, business executives, regulators, directors of research, and institutions.
• Stay ahead of the information curve -- the scope of the Report will expand along with the life sciences industry, with every advance in technology.

Product Structure

Notification: current reports providing news and developments

Formats and Frequency

Print and Web notification formats are issued and available biweekly.

• Antitrust
• Bioinformatics
• Biotechnology
• Bioterrorism countermeasures
• Clinical research
• Combination products
• Collaborative agreements
• Coverage and reimbursement policies
• Data banks
• Drug delivery
• Emerging technologies
• Food & Drug Administration
• Fraud and abuse
• Funding/financing
• Genomic medicine
• Government contracting
• Health care regulations/compliance
• Information technology
• Intellectual property
• Joint ventures
• Licensing agreements
• Mergers and acquisitions
• Nanotechnology
• Patents
• Pharmaceuticals
• Pharmacogenomics
• Sales and marketing
• Securities
• Stem cells
• Taxation
• Technology transfers
• Therapeutic proteins
• Tissue banks/secondary research
• Venture capital